MediWound (NASDAQ:MDWD) executives said 2025 marked a “pivotal year” for the company, highlighting progress in its late-stage EscharEx chronic wound program and the completion of an expanded ...

MediWound Ltd. (NASDAQ:MDWD) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good day, everyone, and welcome to MediWound Ltd.’s Fourth Quarter and Full Year 2025 Earnings Call. Today’s ...

Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...

Successful recovery from forelimb lameness is about more than just the right clinical diagnosis. It often comes down to what happens once the patient leaves the exam room. In this ...

Customer experience breakdowns rarely originate at the touchpoint—they stem from executive decisions made months earlier in ...